Back
Xylem Vs. Harmony Biosciences Holdings Industry Stock Comparison
Sell
49
XYL
Xylem
Last Price:
127.84
Seasonality Move:
1.25%
Sell
3
HRMY
Harmony Biosciences Holdings
Last Price:
29.38
Seasonality Move:
5.31%
Sell
49
Xylem (XYL)
is a Sell
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $127.16. The Score for XYL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- XYL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
3
Harmony Biosciences Holdings (HRMY)
is a Sell
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $29.07. The Score for HRMY is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
- HRMY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
XYL Stock Price Chart
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $29.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRMY is experiencing selling pressure, which indicates risk of future bearish movement.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 48.95 | Sell |
| Chaikin Money Flow: | -765995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.37 - 129.03) | Sell |
| Bollinger Bands (100): | (110.21 - 127.31) | Buy |
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 39.69 | Sell |
| Chaikin Money Flow: | -191353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.97 - 33.01) | Sell |
| Bollinger Bands (100): | (30.41 - 33.13) | Sell |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127.84 | Sell |
| 20-day SMA: | 128.25 | Sell |
| 50-day SMA: | 126.8 | Buy |
| 200-day SMA: | 109.18 | Buy |
| 8-day EMA: | 127.56 | Sell |
| 20-day EMA: | 127.73 | Sell |
| 50-day EMA: | 125.15 | Buy |
| 200-day EMA: | 113.35 | Buy |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.81 | Sell |
| 20-day SMA: | 31.31 | Sell |
| 50-day SMA: | 31.9 | Sell |
| 200-day SMA: | 31.48 | Sell |
| 8-day EMA: | 29.8 | Sell |
| 20-day EMA: | 30.7 | Sell |
| 50-day EMA: | 31.33 | Sell |
| 200-day EMA: | 32.67 | Sell |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.40 per share, and an increase next year of $0.51 per share.
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.38 per share, an increase this year of $0.59 per share, and an increase next year of $1.63 per share.
Xylem Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Harmony Biosciences Holdings Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||